Position in VTRS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$200,929
+$30,541 QoQ
Shares Held
12,653
+0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#572
of 1,016 holders
Holding Since
Dec 2020
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Prime Capital Investment Advisors, LLC holds $767,683 across 2 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (26.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,046 | $566,754 | |
| 2 | VTRS |
Viatris Inc
This page
|
12,653 | $200,929 |
All Filings in VTRS
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $200,929 | 12,653 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $170,388 | 12,612 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $159,646 | 12,823 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $127,512 | 12,880 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $114,241 | 12,793 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $94,939 | 10,900 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $129,467 | 10,399 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $123,959 | 10,677 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $111,455 | 10,485 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $138,181 | 11,573 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $126,461 | 11,677 | Shares | Sole | 2024-01-24 | |
| 2021-03-31 | $15,017 | 1,075 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $69,506 | 3,709 | Shares | Sole | 2021-02-03 | |
| No filing history on record for this holder in this stock. | ||||||